• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏CB1大麻素受体损害可卡因自我给药行为。

Lack of CB1 cannabinoid receptor impairs cocaine self-administration.

作者信息

Soria Guadalupe, Mendizábal Victoria, Touriño Clara, Robledo Patricia, Ledent Catherine, Parmentier Marc, Maldonado Rafael, Valverde Olga

机构信息

Laboratori de Neurofarmacologia, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.

出版信息

Neuropsychopharmacology. 2005 Sep;30(9):1670-80. doi: 10.1038/sj.npp.1300707.

DOI:10.1038/sj.npp.1300707
PMID:15742004
Abstract

Acute rewarding properties are essential for the establishment of cocaine addiction, and multiple neurochemical processes participate in this complex behavior. In the present study, we used the self-administration paradigm to evaluate the role of CB1 cannabinoid receptors in several aspects of cocaine reward, including acquisition, maintenance, and motivation to seek the drug. For this purpose, both CB1 receptor knockout mice and wild-type littermates were trained to intravenously self-administer cocaine under different schedules. Several cocaine training doses (0.32, 1, and 3.2 mg/kg/infusion) were used in the acquisition studies. Only 25% of CB1 knockout mice vs 75% of their wild-type littermates acquired a reliable operant responding to self-administer the most effective dose of cocaine (1 mg/kg/infusion), and the number of sessions required to attain this behavior was increased in knockout mice. Animals reaching the acquisition criteria were evaluated for the motivational strength of cocaine as a reinforcer under a progressive ratio schedule. The maximal effort to obtain a cocaine infusion was significantly reduced after the genetic ablation of CB1 receptors. A similar result was obtained after the pharmacological blockade of CB1 receptors with SR141716A in wild-type mice. Moreover, the cocaine dose-response curve was flattened in the knockout group, suggesting that the differences observed between genotypes were related to changes in the reinforcing efficacy of the training dose of cocaine. Self-administration for water and food was not altered in CB1 knockout mice in any of the reinforcement schedules used, which emphasizes the selective impairment of drug reinforcement in these knockout mice. Finally, cocaine effects on mesolimbic dopaminergic transmission were evaluated by in vivo microdialysis in these mice. Acute cocaine administration induced a similar enhancement in the extracellular levels of dopamine in the nucleus accumbens of both CB1 knockout and wild-type mice. This work clearly demonstrates that CB1 receptors play an important role in the consolidation of cocaine reinforcement, although are not required for its acute effects on mesolimbic dopaminergic transmission.

摘要

急性奖赏特性对于可卡因成瘾的形成至关重要,多种神经化学过程参与了这一复杂行为。在本研究中,我们使用自我给药范式来评估CB1大麻素受体在可卡因奖赏的多个方面所起的作用,包括获取、维持以及寻求药物的动机。为此,我们训练CB1受体基因敲除小鼠和野生型同窝小鼠在不同给药方案下静脉内自我给药可卡因。在获取研究中使用了几种可卡因训练剂量(0.32、1和3.2毫克/千克/输注)。只有25%的CB1基因敲除小鼠与75%的野生型同窝小鼠学会了对自我给药最有效剂量的可卡因(1毫克/千克/输注)做出可靠的操作性反应,并且基因敲除小鼠达到这一行为所需的实验次数增加。达到获取标准的动物在累进比率方案下被评估可卡因作为强化物的动机强度。CB1受体基因缺失后,获取一次可卡因输注的最大努力显著降低。在野生型小鼠中用SR141716A对CB1受体进行药理学阻断后也得到了类似结果。此外,基因敲除组的可卡因剂量-反应曲线变平,这表明不同基因型之间观察到的差异与可卡因训练剂量的强化效力变化有关。在所用的任何强化方案中,CB1基因敲除小鼠对水和食物的自我给药均未改变,这强调了这些基因敲除小鼠中药物强化的选择性损伤。最后,通过对这些小鼠进行体内微透析来评估可卡因对中脑边缘多巴胺能传递的影响。急性给予可卡因在CB1基因敲除小鼠和野生型小鼠的伏隔核细胞外多巴胺水平上均诱导了类似的升高。这项工作清楚地表明,CB1受体在可卡因强化巩固中起重要作用,尽管其对中脑边缘多巴胺能传递的急性作用并不需要CB1受体。

相似文献

1
Lack of CB1 cannabinoid receptor impairs cocaine self-administration.缺乏CB1大麻素受体损害可卡因自我给药行为。
Neuropsychopharmacology. 2005 Sep;30(9):1670-80. doi: 10.1038/sj.npp.1300707.
2
Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.大麻素CB1受体拮抗剂可减弱可卡因的奖赏效应:大鼠自我给药及脑刺激奖赏实验
Neuropsychopharmacology. 2008 Jun;33(7):1735-45. doi: 10.1038/sj.npp.1301552. Epub 2007 Aug 29.
3
Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.大麻素CB1受体拮抗剂利莫那班对大鼠巧克力味饮料强化和激励特性的抑制作用。
Behav Pharmacol. 2008 May;19(3):197-209. doi: 10.1097/FBP.0b013e3282fe8888.
4
CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.CB1大麻素受体调节3,4-亚甲基二氧甲基苯丙胺的急性反应及强化作用。
Biol Psychiatry. 2008 Jun 1;63(11):1030-8. doi: 10.1016/j.biopsych.2007.09.003. Epub 2007 Oct 24.
5
Effect of cannabinoid CB1 receptor antagonist SR141716A and CB1 receptor knockout on cue-induced reinstatement of Ensure and corn-oil seeking in mice.大麻素CB1受体拮抗剂SR141716A和CB1受体基因敲除对小鼠线索诱导的Ensure和玉米油觅求恢复的影响。
Neuropsychopharmacology. 2007 Dec;32(12):2592-600. doi: 10.1038/sj.npp.1301384. Epub 2007 Mar 28.
6
Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice.性别和大麻素CB1基因分型可区分小鼠对美味食物和可卡因的自我给药行为。
Behav Pharmacol. 2009 Oct;20(7):605-13. doi: 10.1097/FBP.0b013e328331ba30.
7
The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.大麻素 CB1、CB2 和香草素 TRPV1 受体拮抗剂对大鼠可卡因成瘾行为的影响。
Brain Res. 2012 Mar 20;1444:45-54. doi: 10.1016/j.brainres.2012.01.030. Epub 2012 Jan 20.
8
Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway.大麻素通过腹侧纹状体苍白球通路对阿片类强化作用的调节
Neuropsychopharmacology. 2006 Apr;31(4):804-13. doi: 10.1038/sj.npp.1300848.
9
The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine.A2A 腺苷受体的缺失会降低可卡因的强化效力。
Neuropsychopharmacology. 2006 May;31(5):978-87. doi: 10.1038/sj.npp.1300876.
10
Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice.M4 毒蕈碱型乙酰胆碱受体基因敲除小鼠可卡因自我给药增加。
Psychopharmacology (Berl). 2011 Aug;216(3):367-78. doi: 10.1007/s00213-011-2225-4. Epub 2011 Mar 5.

引用本文的文献

1
Changes of CB1 Receptor Expression in Tissues of Cocaine-Exposed Eels.可卡因暴露鳗鱼组织中CB1受体表达的变化。
Animals (Basel). 2025 Jun 12;15(12):1734. doi: 10.3390/ani15121734.
2
The effect of a synthetic cannabinoid agonist (nabilone) on unimodal tactile illusion correlates with a psychometric scores in healthy volunteers.合成大麻素激动剂(那必隆)对单峰触觉错觉的影响与健康志愿者的心理测量分数相关。
Sci Rep. 2025 May 27;15(1):18469. doi: 10.1038/s41598-025-02280-9.
3
Altered integrated and segregated states in cocaine use disorder.
可卡因使用障碍中整合与分离状态的改变。
Front Neurosci. 2025 Apr 9;19:1572463. doi: 10.3389/fnins.2025.1572463. eCollection 2025.
4
Lack of Bmal1 leads to changes in rhythmicity and impairs motivation towards natural stimuli.缺乏 Bmal1 会导致节律变化,并损害对自然刺激的动机。
Open Biol. 2024 Jul;14(7):240051. doi: 10.1098/rsob.240051. Epub 2024 Jul 24.
5
Role of mesolimbic cannabinoid receptor 1 in stress-driven increases in cocaine self-administration in male rats.中脑边缘型大麻素受体 1 在雄性大鼠应激驱动可卡因自我给药增加中的作用。
Neuropsychopharmacology. 2023 Jul;48(8):1121-1132. doi: 10.1038/s41386-023-01589-1. Epub 2023 May 15.
6
Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation.内源性大麻素系统与中脑多巴胺能系统之间的相互作用:对多巴胺调节异常的影响。
Front Behav Neurosci. 2023 Mar 16;17:1137957. doi: 10.3389/fnbeh.2023.1137957. eCollection 2023.
7
Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.突触内外的内源性大麻素:对神经精神疾病病理生理学和治疗的影响。
Neuropsychopharmacology. 2023 Jan;48(1):37-53. doi: 10.1038/s41386-022-01438-7. Epub 2022 Sep 13.
8
CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects.大麻素受体 1 沉默可减轻氯胺酮诱导的过度活跃,而不影响其抗抑郁样作用。
Cannabis Cannabinoid Res. 2023 Oct;8(5):768-778. doi: 10.1089/can.2022.0072. Epub 2022 Sep 2.
9
Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research.PIMSR 作为一种新型的 CB1 受体中性拮抗剂,在可卡因使用障碍治疗中的潜力:来自临床前研究的证据。
Transl Psychiatry. 2022 Jul 18;12(1):286. doi: 10.1038/s41398-022-02059-w.
10
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.精神疾病中环核苷酸系统的分子改变。
Int J Mol Sci. 2022 Apr 26;23(9):4764. doi: 10.3390/ijms23094764.